Premark Pharma Licenses Worldwide Rights to PMP2207 for Ophthalmic Indications and Targets a First Regulatory Approval for Blepharitis
BASEL, SWITZERLAND / ACCESSWIRE / June 25, 2019 / Premark Pharma announced today the completion of a licensing deal with...